During the past decade, Rheumatologische Schwerpunktpraxis conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 2 clinical trials were completed, i.e. on average, 25% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 1 clinical trials were completed. i.e. 20% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Rheumatologische Schwerpunktpraxis" #1 sponsor was "Pfizer" with 2 trials, followed by "ACELYRIN Inc." with 1 trials sponsored, "Charite University, Berlin, Germany" with 1 trials sponsored, "Galapagos NV" with 1 trials sponsored and "Janssen Pharmaceutica N.V., Belgium" with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Rheumatologische Schwerpunktpraxis" #1 collaborator was "Amgen" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Rheumatologische Schwerpunktpraxis" are "Arthritis, Psoriatic" (2 trials), "Psoriatic Arthritis" (2 trials), "Rheumatoid Arthritis" (2 trials), "Ankylosing Spondylitis" (1 trials) and "Spondylitis, Ankylosing" (1 trials). Many other conditions were trialed in "Rheumatologische Schwerpunktpraxis" in a lesser frequency.

Most popular intervention types in "Rheumatologische Schwerpunktpraxis" are "Drug" (5 trials), "Biological" (3 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "Guselkumab" (2 trials), "ABY-035" (1 trials), "Celecoxib" (1 trials) and "Etanercept" (1 trials). Other intervention names were less common.

The vast majority of trials in "Rheumatologische Schwerpunktpraxis" are 8 trials for "All" genders.

Currently, there are NaN active trials in "Rheumatologische Schwerpunktpraxis". undefined are not yet recruiting, 4 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Rheumatologische Schwerpunktpraxis, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Rheumatologische Schwerpunktpraxis, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 0 trials that are defined as “Not Applicable".